跳至主要内容
临床试验/KCT0008362
KCT0008362尚未招募Unknown

A randomized comparaTive study Of rosuvastatin/ezetimibe 20/10mg and atorvastatin/ezetimibe 40/10mg in patients with coronary artery drug eLuting stEnt implantation Requiring high-dose stAtin/ezetimibe combiNaTion therapy: TOLERANT Trial

Yonsei University Yongin Severance Hospital0 个研究点目标入组 200 人开始时间: 待定最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19(Year) 至 o Limit(—)
性别
All

入选标准

  • 1. 19 years of age or older
  • 2. Patients who underwent a new generation of drug elution stent implantation for cardiovascular disease

排除标准

  • 1. LDL cholesterol levels below 55 mg/dL without statin treatment
  • 2. Serum AST/ALT with an acute liver disease within a month or a normal upper limit that is not continuously explained
  • 3. Allergies or overreactions to statins
  • 4. Estimated Dawn of Less than 1 Year
  • 5. If it is determined that follow-up is not possible for more than one year
  • 6. Pregnancy

研究者

发起方
Yonsei University Yongin Severance Hospital

相似试验